Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Lazova, R; Seeley, EH; Kutzner, H; Scolyer, RA; Scott, G; Cerroni, L; Fried, I; Kozovska, ME; Rosenberg, AS; Prieto, VG; Shehata, BM; Durham, MM; Henry, G; Rodriguez-Peralto, JL; Riveiro-Falkenbach, E; Schaefer, JT; Danialan, R; Fraitag, S; Vollenweider-Roten, S; Sepehr, A; Sangueza, M; Hijazi, N; Corredoira, Y; Kowal, R; Harris, OM; Bravo, F; Boyd, AS; Gueorguieva, R; Caprioli, RM.
Imaging mass spectrometry assists in the classification of diagnostically challenging atypical Spitzoid neoplasms.
J Am Acad Dermatol. 2016; 75(6):1176-1186
Doi: 10.1016/j.jaad.2016.07.007
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
- Cerroni Lorenzo
- Fried Isabella
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Previously, using imaging mass spectrometry (IMS), we discovered proteomic differences between Spitz nevi and Spitzoid melanomas. We sought to determine whether IMS can assist in the classification of diagnostically challenging atypical Spitzoid neoplasms (ASN), to compare and correlate the IMS and histopathological diagnoses with clinical behavior. We conducted a retrospective collaborative study involving centers from 11 countries and 11 US institutions analyzing 102 ASNs by IMS. Patients were divided into clinical groups 1 to 4 representing best to worst clinical behavior. The association among IMS findings, histopathological diagnoses, and clinical groups was assessed. There was a strong association between a diagnosis of Spitzoid melanoma by IMS and lesions categorized as clinical groups 2, 3, and 4 (recurrence of disease, metastases, or death) compared with clinical group 1 (no recurrence or metastasis beyond a sentinel node) (P < .0001). Older age and greater tumor thickness were strongly associated with poorer outcome (P = .01). IMS diagnosis of ASN better predicted clinical outcome than histopathology. Diagnosis of Spitzoid melanoma by IMS was strongly associated with aggressive clinical behavior. IMS analysis using a proteomic signature may improve the diagnosis and prediction of outcome/risk stratification for patients with ASN. Copyright © 2016 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.
- Find related publications in this database (using NLM MeSH Indexing)
- Adolescent -
- Adult -
- Age Factors -
- Aged -
- Aged, 80 and over -
- Child -
- Child, Preschool -
- Diagnosis, Differential -
- Female -
- Humans -
- Lymphatic Metastasis -
- Male -
- Mass Spectrometry -
- Melanoma - chemistry
- Melanoma - diagnostic imaging
- Melanoma - secondary
- Middle Aged -
- Neoplasm Recurrence, Local - chemistry
- Neoplasm Recurrence, Local - diagnostic imaging
- Neoplasm Recurrence, Local - pathology
- Nevus, Epithelioid and Spindle Cell - chemistry
- Nevus, Epithelioid and Spindle Cell - diagnostic imaging
- Nevus, Epithelioid and Spindle Cell - pathology
- Proteins - analysis
- Retrospective Studies -
- Risk Assessment -
- Sentinel Lymph Node Biopsy -
- Skin Neoplasms - chemistry
- Skin Neoplasms - diagnostic imaging
- Skin Neoplasms - pathology
- Treatment Outcome -
- Tumor Burden -
- Young Adult -
- Find related publications in this database (Keywords)
- atypical Spitzoid neoplasm
- histopathology
- imaging mass spectrometry
- mass spectrometry
- Spitz nevus
- Spitzoid melanoma